---
title: "Inspire Medical Systems GAAP EPS of $1.15 beats by $0.43, revenue of $239.72M beats by $2.31M"
date: "2025-02-11 00:05:28"
summary: "Inspire Medical Systems press release (NYSE:INSP): Q4 GAAP EPS of $1.15 beats by $0.43. Revenue of $239.72M (+24.5% Y/Y) beats by $2.31M. Shares -0.09%. Full Year 2025 Guidance Inspire’s previously announced full year 2025 revenue guidance remains between $940 million to $955 million, vs. $801.38M consensus, which represents expected growth..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Inspire Medical Systems [press release](https://seekingalpha.com/pr/19997234-inspire-medical-systems-inc-announces-fourth-quarter-and-full-year-2024-financial-results-and) (NYSE:[INSP](https://seekingalpha.com/symbol/INSP "Inspire Medical Systems, Inc.")): Q4 GAAP EPS of $1.15  beats by $0.43.
* Revenue of $239.72M (+24.5% Y/Y)  beats by $2.31M.
* Shares -0.09%.
* Full Year 2025 Guidance
  
  Inspire’s previously announced full year 2025 revenue guidance remains between $940 million to $955 million, vs. $801.38M consensus, which represents expected growth of 17% to 19% over full year 2024 revenue of $802.8 million.
  
  Gross margin for the full year is anticipated to be in the range of 84% to 86%.
  
  Inspire is introducing full year 2025 diluted earnings per share guidance of $2.10 to $2.20.

[seekalpha](https://seekingalpha.com/news/4405787-inspire-medical-systems-gaap-eps-of-1_15-beats-by-0_43-revenue-of-239_72m-beats-by-2_31m)
